Related Experiment Video
Updated: Jan 1, 2026

11:04
Author Spotlight: Methods for Electroporation and Transformation Confirmation in Limosilactobacillus reuteri DSM20016
Published on: June 23, 2023
4.8K
Microbial Transformation of Licochalcones
Yina Xiao1, Fubo Han1, Ik-Soo Lee1
1College of Pharmacy, Chonnam National University, Gwangju 61186, Korea.
Molecules (Basel, Switzerland)
|December 28, 2019
Summary
Microbial transformation of licochalcones yielded ten new metabolites. This study expands the structural diversity of retrochalcones, aiding further biological investigations and understanding isomerization mechanisms.
Area of Science:
- Natural Product Chemistry
- Microbiology
- Synthetic Chemistry
Background:
- Licochalcones are natural compounds with potential biological activities.
- Microbial transformations offer a sustainable route to novel compound derivatives.
- Understanding retrochalcone isomerization is crucial for drug development.
Purpose of the Study:
- Investigate microbial transformation of licochalcones B, C, D, and H.
- Isolate and characterize novel metabolites produced by fungal strains.
- Determine the structures and absolute configurations of new compounds.
Main Methods:
- Utilized filamentous fungi Aspergillus niger and Mucor hiemalis for biotransformation.
- Employed chromatographic techniques for metabolite isolation.
- Characterized compounds using UV, IR, MS, NMR, CD, and ECD spectroscopy.
Main Results:
- Isolated ten new metabolites: one hydrogenated, three dihydroxylated, three epoxidized, and three glucosylated.
- Determined absolute configurations of dihydroxylated metabolites using ECD.
- Observed trans-cis isomerization in four metabolites, providing insights into the mechanism.
Conclusions:
- Fungal transformation effectively expands the structural diversity of retrochalcones.
- The study provides new insights into the trans-cis isomerization of retrochalcones.
- Generated novel compounds for future biological activity screening and drug discovery.
Related Concept Videos
Transformation
596
Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...
596
Bacterial Transformation
59.2K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.2K
Drug Biotransformation: Overview
3.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.4K

